Study on protective effects of Panax notoginseng saponins on doxorubicin-induced myocardial damage

Zhongguo Zhongyao Zazhi

Volumn 32, Issue 24, 2007, Pages 2632-2635

  Shi, Run ^a   Liu, Li ^a   Huo, Yang ^a   Cheng, Yi Yu ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Doxorubicin; Myocardial injury; Panax notoginseng saponins; Protection

Indexed keywords

CARDIOTONIC AGENT; CREATINE KINASE; CREATINE KINASE MB; DOXORUBICIN; GINSENOSIDE; LACTATE DEHYDROGENASE;

ANIMAL; ARTICLE; BLOOD; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; HEART MUSCLE CELL; HERB DRUG INTERACTION; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; ISOLATION AND PURIFICATION; MALE; MEDICINAL PLANT; MOUSE; PANAX NOTOGINSENG; RANDOMIZATION; RAT; TUMOR CELL LINE;

ANIMALS; CARDIOTONIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CREATINE KINASE; CREATINE KINASE, MB FORM; DOXORUBICIN; GINSENOSIDES; HERB-DRUG INTERACTIONS; HUMANS; LACTATE DEHYDROGENASES; MALE; MICE; MICE, INBRED ICR; MYOCYTES, CARDIAC; PANAX NOTOGINSENG; PLANTS, MEDICINAL; RANDOM ALLOCATION; RATS;

EID: 38549106530     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Dorshow J H. Doxorubicin-induced cardiac toxicity [J]. N Eng J Med, 1991, 324:843.
2. Luksana Chaiswing, Marsha P Cole, Wanida Ittarat, et al. Manganese superoxide dismutase and inducible nitric oxide synthase modify early oxidative events in acute Adriamycin-induced mito-chondrial toxicity [J]. Mol Cancer Ther, 2005, 4(7) : 1056.
3. Chinese source
4. Medha Rajappa, M D, Alpana Sharma, PhD. Biomarkers of cardiac injury: an update[J]. Angiology, 2005, 56(6) :677.
5. Seifert C F, Nesser M E, Thompson D F. Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity[ J]. Annals Pharmacotherapy, 1994, 28(9) : 1063.
6. Chen Y J, Li J D, Huang Q F. Effects of Panax notoginseng saponins on rat cardiomyocytes apoptosis induced by angiotengin II in vitro[J]. Zhongguo Zhong Yao Za Zhi, 2005, 30(10) : 778.
7. April C Childs, Sharon L Phaneuf, Amie J, et al. Doxorubicin treatment in vivo causes cytochrome crelease and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and bcl-2 : bax ratio [J]. Cancer Research, 2002, 62 :4592.